Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Luc Fornecker"'
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7175-7181 (2023)
Abstract Background Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low‐dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this stu
Externí odkaz:
https://doaj.org/article/63f3a6ecd43b4f86b0b0537085a06afc
Autor:
Pierre Bories, Sébastien Lamy, Célestine Simand, Sarah Bertoli, Cyrille Delpierre, Sandra Malak, Luc Fornecker, Stéphane Moreau, Christian Récher, Antoine Nebout
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
Elderly patients with acute myeloid leukemia can be treated with intensive chemotherapy, low-intensity therapy such as low-dose aracytine or hypomethylating agents, or best supportive care. The choice between these treatments is a function of many pa
Externí odkaz:
https://doaj.org/article/79e706bb147e4d198f78bb48bf6097ff
Autor:
Eric Van Den Neste, Olivier Casasnovas, Marc André, Mohamed Touati, Delphine Senecal, Véronique Edeline, Aspasia Stamatoullas, Luc Fornecker, Bénédicte Deau, Thomas Gastinne, Oumédaly Reman, Isabelle Gaillard, Cécile Borel, Pauline Brice, Christophe Fermé
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
The Hodgkin’s Lymphoma Committee of the Lymphoma Study Association (LYSA) gathered in 2012 to prepare guidelines on the management of transplant-eligible patients with relapsing or refractory Hodgkin’s lymphoma. The working group is made up of a
Externí odkaz:
https://doaj.org/article/e040960e05534e6c9bd9eeaf36a0dc45
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine. 12:7175-7181
Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low-dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this study, venetoclax was not
Autor:
Carole Mathelin, Emmanuel Barranger, Martine Boisserie-Lacroix, Gérard Boutet, Susie Brousse, Nathalie Chabbert-Buffet, Charles Coutant, Emile Daraï, Yann Delpech, Martha Duraes, Marc Espié, Luc Fornecker, François Golfier, Pascale Grosclaude, Anne Sophie Hamy, Edith Kermarrec, Vincent Lavoué, Massimo Lodi, Élisabeth Luporsi, Christine M. Maugard, Sébastien Molière, Jean-Yves Seror, Nicolas Taris, Catherine Uzan, Charlotte Vaysse, Xavier Fritel
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 50:107-120
Autor:
Gandhi Damaj, Steven Le Gouill, Christophe Bonnet, Hervé Ghesquières, David Sibon, Marc André, Emmanuel Itti, Loïc Chartier, Françoise Kraeber-Bodéré, Luc Fornecker, Hervé Tilly, Vincent Ribrag, Franck Morschhauser, Jean-Philippe Jais, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Krimo Bouhabdallah, Philippe Ruminy, Guillaume Cartron, Catherine Thieblemont, Remy Gressin, Reda Bouhabdallah, Corinne Haioun, Lucie Oberic, Thierry Jo Molina, René-Olivier Casasnovas, Pierre Feugier, Josette Brière, Thierry Lamy, Hervé Maisonneuve
Publikováno v:
Blood. 137:2307-2320
Rituximab plus polychemotherapy is the standard of care in diffuse large B-cell lymphoma (DLBCL). GAINED, a randomized phase 3 trial, compared obinutuzumab to rituximab. Transplant-eligible patients (18-60 years) with an untreated age-adjusted Intern
Tube-Gel: A Fast and Effective Sample Preparation Method for High-Throughput Quantitative Proteomics
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1959
Sample preparation is a key step in proteomics workflows. Tube-gel (TG) is a fast and repeatable sample preparation method that consists in the instantaneous trapping of the sample in a polyacrylamide gel matrix. It takes advantage of in-gel sample p
Tube-Gel: A Fast and Effective Sample Preparation Method for High-Throughput Quantitative Proteomics
Publikováno v:
Proteomics for biomarker discovery
Proteomics for biomarker discovery, pp.123-127, 2019, ⟨10.1007/978-1-4939-9164-8_8⟩
Methods in Molecular Biology ISBN: 9781493991631
Proteomics for biomarker discovery, pp.123-127, 2019, ⟨10.1007/978-1-4939-9164-8_8⟩
Methods in Molecular Biology ISBN: 9781493991631
International audience; Sample preparation is a key step in proteomics workflows. Tube-gel (TG) is a fast and repeatable sample preparation method that consists in the instantaneous trapping of the sample in a polyacrylamide gel matrix. It takes adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79869dfdb4539c06da40a0291d789978
https://hal.archives-ouvertes.fr/hal-02341533/file/Tube_Gel_Chapter_Muller_et_al_FINAL.pdf
https://hal.archives-ouvertes.fr/hal-02341533/file/Tube_Gel_Chapter_Muller_et_al_FINAL.pdf
Autor:
Loic Ysebaert, Anne Banos, Vincent Delwail, Roch Houot, Nicolas Daguindau, Reda Garidi, Margaret Macro, Ghandi Damaj, Bertrand Joly, Jean Pierre Vilque, Sylvain Carras, Mary Callanan, Fabrice Jardin, Marie Pierre Moles, Magda Alexis, Steven Le Gouill, Emmanuelle Tchernonog, Laurent Voillat, Hacene Zerazhi, Christiane Mounier, J. Fleury, Sandy Amorin, Anne Moreau, Jean Michel Pignon, Adrian Tempescul, Véronique Dorvaux, Yazid Arkam, Luc Fornecker, Caroline Dartigeas, Cecile Chabrot, Philippe Solal Celigny, Pierre Feugier, Remy Gressin, Anna Schmitt, Jean Fontan, Clémentine Sarkozy, Nadine Morineau, Jehan Dupuis, Selim Corm, Krimo Bouadallah
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2018, 104 (1), pp.138-146. ⟨10.3324/haematol.2018.191429⟩
Haematologica, Ferrata Storti Foundation, 2018, 104 (1), pp.138-146. ⟨10.3324/haematol.2018.191429⟩
International audience; We present results of a prospective, multicenter, phase II study evaluating rituximab, bendamustine, bortezomib and dexamethasone as first-line treatment for patients with mantle cell lymphoma aged 65 years or older. A total o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95cbd06f520ccbc6898f00caf6e8a39
https://hal.archives-ouvertes.fr/hal-02265274
https://hal.archives-ouvertes.fr/hal-02265274
Autor:
Ariane Boumendil, Anne Corby, Emmanuelle Nicolas-Virelizier, David Pohlreich, Wilfried Schroyens, Reuven Or, Herve Finel, Juergen Finke, Luc Fornecker, Xavier Poiré, Peter Dreger, Catherine Thieblemont, Dolores Caballero, Harry C. Schouten, Arnon Nagler, Emmanuel Bachy, Didier Blaise, Lionel Vincent, Stephen P. Robinson, Ram Malladi
Publikováno v:
Bone Marrow Transplantation, 51(3), 365-371. Nature Publishing Group
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2016, 51 (3), pp.365-371. ⟨10.1038/bmt.2015.286⟩
Bone marrow transplantation
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2016, 51 (3), pp.365-371. ⟨10.1038/bmt.2015.286⟩
Bone marrow transplantation
International audience; In the era of chemoimmunotherapy, the optimal treatment paradigm for relapsed and refractory diffuse large B-cell lymphoma has been challenged. We reviewed the outcome of standard salvage therapy with an autologous stem cell t